![Matthew Greenhawt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Greenhawt
Corporate Officer/Principal bei Intrommune Therapeutics, Inc.
Aktive Positionen von Matthew Greenhawt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Intrommune Therapeutics, Inc.
![]() Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Karriereverlauf von Matthew Greenhawt
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Sektoral
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Intrommune Therapeutics, Inc.
![]() Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
- Börse
- Insiders
- Matthew Greenhawt
- Erfahrung